NEWS

BioPhorum Technology Strategy – accelerating your technology transformation and adoption

1 March 2023
Technology Strategy
Andrea Johnston, PhD
Phorum Director

The biopharmaceutical industry is undergoing rapid growth and is challenged to deliver multi-modality products to a patient-centric global market. However, this requires a significant transformation in strategy, technology, R&D, and manufacturing.

This is where BioPhorum Technology Strategy will play a leading role.

BioPhorum Technology Strategy is the new name for BioPhorum Technology Roadmapping, which originated in 2015 from the need to address emerging biopharmaceutical industry challenges and opportunities. Eight years later, and after publishing our overarching Technology Roadmap 2.0 we recognized that roadmapping activities were largely complete and we needed the Phorum to transition to its next Technology Strategy phase.

Building on the original initiatives, BioPhorum Technology Strategy portfolio offers members realizable benefits spanning a timeline from one year to 10, depending on whether the focus of activity is proofs-of-concept, technology acceleration or further roadmapping.

The refreshed Phorum also offers benefits from a broader BioPhorum perspective, such as enhanced connectivity with the Information Technology, Sustainability, and Drug Substance Phorums. Enhanced membership models working across Technology Strategy and related phorums are now available including the newly launched Analytical and Instrument Providers. As a member, you will be able to realize benefits directly in your own organization, including:

  • Increased plant asset utilization
  • Reduced time for plant reconfiguration
  • Increased speed to market
  • Reduced cost of goods
  • Increased quality of supply
  • Reduced material usage and waste.

The Phorum’s portfolio will initially focus on three priority areas:

  • Ultimate facility design (multi-modal and towards ‘lights out’ manufacture)
  • Autonomous and advanced process control
  • Knowledge management for future manufacturing.
biophorum uncategorized tr strategy 106

BioPhorum Technology Strategy will continue to be the home for innovation for stakeholders across the eco-system and technology readiness levels. Our team comes from 50+ member organizations and has 600+ thought leaders and subject matter experts from biomanufacturers and suppliers, including analytical instrument, engineering, and automation providers. It will also continue collaborating with regulators, standards agencies, academics, and innovation hubs to provide innovative technological solutions to enable flexible and resilient end-to-end biomanufacturing.

biophorum post images technology strategy 4 1920 504

Making connections

The first BioPhorum Technology Strategy face-to-face Steering Committee meeting will be held on the US East Coast in May and will be co-located with Drug Substance to explore synergies and find collaborative opportunities. The new Phorum’s Analytical Provider, Engineering Partner, and Robotics and Automation Provider memberships are also building connections at a cross-phorum level.

BioPhorum Technology Strategy seeks to grow and strengthen roadmapping activities aligned with industry megatrends, progress the Digital Technology Roadmap 2.0, and Robotics and Automation activities for ‘lights out’ manufacture. We will also continue to identify areas for proof-of-concept to demonstrate the technical and business feasibility of solutions. Technology adoption will be accelerated through access to resources such as podcasts, white papers, blueprints, adoption frameworks, standards, and digital assets.

How are you accelerating your technology transformation and adoption?

If you would like to get involved in any aspects of the Phorum or to find out more, please get in touch with Andrea Johnston, PhD, BioPhorum Technology Strategy Director, at andrea.johnston@biophorum.com

NEWS
A major milestone – a harmonized approach to product carbon footprint data
NEWS
Combination products – MediPhorum’s ‘state of the nation’ report
NEWS
Inaugural BioPhorum Quality face to face – get involved
NEWS
Forecasting the demand for single-use systems
NEWS
The new Drug Substance Strategic Value Framework – addressing industry pain points

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.

Quality

BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.

Regulatory-CMC

Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.

Sustainability

Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

DOWNLOAD
An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
EXTERNAL-RESOURCE
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
DOWNLOAD
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
DOWNLOAD
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
NEWS
Inaugural BioPhorum Quality face to face – get involved
PODCAST
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
PODCAST
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
DOWNLOAD
A vision for the biopharmaceutical industry’s inbound supply chain
NEWS
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
DOWNLOAD
BioPhorum Technology Roadmapping roadmap vision 2.0

Publications

Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.

Webinars

Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.

Podcasts

BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.

Tools

A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
WEBINAR
Bioreactivity testing in single-use system biomanufacturing